1. Home
  2. SGHT vs PNNT Comparison

SGHT vs PNNT Comparison

Compare SGHT & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$6.90

Market Cap

395.5M

Sector

Health Care

ML Signal

HOLD

Logo PennantPark Investment Corporation

PNNT

PennantPark Investment Corporation

HOLD

Current Price

$6.18

Market Cap

397.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
PNNT
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
395.5M
397.7M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
SGHT
PNNT
Price
$6.90
$6.18
Analyst Decision
Buy
Hold
Analyst Count
8
5
Target Price
$8.23
$5.95
AVG Volume (30 Days)
329.1K
602.6K
Earning Date
03-04-2026
02-09-2026
Dividend Yield
N/A
15.58%
EPS Growth
N/A
N/A
EPS
N/A
0.50
Revenue
$76,052,000.00
$122,377,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$12.07
N/A
P/E Ratio
N/A
$12.29
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$5.66
52 Week High
$9.24
$7.53

Technical Indicators

Market Signals
Indicator
SGHT
PNNT
Relative Strength Index (RSI) 38.11 58.31
Support Level $6.39 $5.89
Resistance Level $7.55 $6.18
Average True Range (ATR) 0.60 0.12
MACD -0.19 0.03
Stochastic Oscillator 17.04 98.75

Price Performance

Historical Comparison
SGHT
PNNT

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

Share on Social Networks: